• About
  • Blog
  1. Home
  2. Blog
  3. Companies
  4. PM

Philip Morris International Inc.(PM)

New York Stock Exchange
Sector: Consumer Defensive | Industry: Tobacco
Philip Morris International Inc. logo

Philip Morris International Inc. operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include products outside of the tobacco and nicotine sector. The company's product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, vapor, and oral nicotine products that are sold in markets outside the United States. The company offers its smoke-free products under the HEETS, HEETS Creations, HEETS Dimensions, HEETS Marlboro, HEETS FROM MARLBORO, Marlboro Dimensions, Marlboro HeatSticks, Parliament HeatSticks, and TEREA brands, as well as the KT&G-licensed brands, Fiit, and Miix. It also sells its products under the Marlboro, Parliament, Bond Street, Chesterfield, L&M, Lark, and Philip Morris brands. In addition, the company owns various cigarette brands, such as Dji Sam Soe, Sampoerna A, and Sampoerna U in Indonesia; and Fortune and Jackpot in the Philippines. The company sells its smoke-free products in 71 markets. Philip Morris International Inc. was incorporated in 1987 and is headquartered in New York, New York.

Latest News & Analysis

Modern smokeless device on reflective surface with abstract smoke and city background
Jun 12, 2025

Philip Morris International's Strategic Pivot: Smoke-Free Dominance

Philip Morris International (PM) is aggressively shifting towards smoke-free products, with IQOS and ZYN driving significant revenue growth amid regulatory changes and illicit trade challenges.

Read more →
Philip Morris International: Navigating Illicit Trade and Smoke-Free Growth
Jun 11, 2025

Philip Morris International: Navigating Illicit Trade and Smoke-Free Growth

Philip Morris International navigates rising illicit trade in the EU while accelerating its shift to smoke-free products, impacting financials and strategic focus.

Read more →
Philip Morris International: Stock Surge, Smoke-Free Growth in 2025
Jun 5, 2025

Philip Morris International: Stock Surge, Smoke-Free Growth in 2025

Philip Morris International's stock surge and strategic pivot to smoke-free products are key themes in 2025, navigating growth amid regulatory shifts and competition.

Read more →
Philip Morris International's smoke-free strategy: A look at IQOS, ZYN, financial performance, and investment potential. Stay informed with our in-depth analysis.
Mar 28, 2025

Philip Morris International: Smoke-Free Revolution & Investor Impact

Philip Morris International (PMI) is strategically transitioning to smoke-free products like IQOS and ZYN, demonstrating strong growth potential.

Read more →
Philip Morris International stock: Zyn nicotine pouches driving growth in smoke-free future.
Mar 24, 2025

Philip Morris (PM): Zyn's Rise, Dividend Concerns, Smoke-Free Future

Philip Morris International is transforming into a smoke-free company, driven by Zyn's popularity. High payout ratio and regulatory challenges pose risks, but growth prospects and defensive characteristics make it an interesting investment.

Read more →
Philip Morris International: ZYN and IQOS driving smoke-free revenue growth. Financial analysis, dividend yield, and market resilience.
Mar 13, 2025

Philip Morris (PM): Smoke-Free Transformation and ZYN's Rise

PMI is transforming, shifting to smoke-free products like ZYN and IQOS. The company's financials are increasingly driven by these products, aiming for two-thirds of revenue from smoke-free sources by 2030.

Read more →
Philip Morris International stock analysis: Smoke-free strategy, dividends, ZYN, and investment outlook.
Mar 10, 2025

Philip Morris (PM): Smoke-Free Strategy, Dividends, and Market Resilience

Philip Morris International navigates a smoke-free future with strategic shifts, dividend focus, and market resilience. A deep dive into PM's financials and strategic moves.

Read more →
Philip Morris International: Intraday Market Analysis, strategic shift to smoke-free products like IQOS and ZYN, and financial insights for investors.
Mar 5, 2025

Philip Morris: Intraday Update on Financial and Strategic Developments

Intraday update on Philip Morris, detailing financial performance, strategic shifts, and market dynamics with verified, real-time data.

Read more →
Philip Morris International's shift to smoke-free products amidst market turmoil: IQOS, ZYN, regulatory challenges, and financial analysis.
Feb 27, 2025

Philip Morris International: Navigating Smoke-Free Future

Philip Morris International navigates a smoke-free future amidst market volatility, driven by IQOS and ZYN growth, regulatory hurdles, and dividend strategies.

Read more →
Philip Morris International's transition to smoke-free products like IQOS and ZYN, investor outlook, and strategic challenges in the evolving tobacco market.
Feb 26, 2025

Philip Morris International: A Smoke-Free Future

Philip Morris International navigates a smoke-free future amid shifting investor sentiment and regulatory changes. IQOS and ZYN drive transformation. CAGNY conference insights.

Read more →
Philip Morris International's Smoke-Free Revolution: An in-depth analysis of PMI's strategic shift, financial health, and future prospects in the evolving market landscape. Explore the growth of IQOS and ZYN, regulatory challenges, and investment considerations for 2025.
Feb 24, 2025

Philip Morris International: Navigating the Smoke-Free Revolution in 2025

Philip Morris International navigates its smoke-free transformation, driven by IQOS and ZYN growth amid evolving regulations and market dynamics.

Read more →
Philip Morris International stock analysis: PMI's smoke-free strategy, Zyn & IQOS growth, regulatory challenges, Q4 2024 earnings.
Feb 21, 2025

Philip Morris International: Smoke-Free Revolution Drives Growth in 2025

Explore PMI’s robust Q4 2024 earnings, its groundbreaking shift to smoke-free products, and the regulatory challenges shaping its future.

Read more →
Philip Morris International: A smoke-free future with IQOS and ZYN. Analyst insights, financial performance, and strategic outlook for PM.
Feb 20, 2025

Philip Morris International: Smoke-Free Future at CAGNY 2025

Philip Morris International focuses on smoke-free future at CAGNY 2025, highlighting IQOS and ZYN growth amid regulatory challenges and market shifts.

Read more →
Close-up of an IQOS device on a dark background.
Feb 20, 2025

PMI's Smoke-Free Future: Q4 Earnings, ZYN Growth & CAGNY 2025 Insights

An in-depth analysis of Philip Morris International’s transformation, Q4 earnings, and breakthrough developments in its smoke-free portfolio.

Read more →
Hand holding a modern nicotine pouch package with blurred background.
Feb 19, 2025

Philip Morris International Navigates the Smoke-Free Future

In-depth analysis of PM’s Q4 earnings, innovative smoke-free strategies, and a shifting regulatory landscape impacting future growth.

Read more →
Philip Morris International logo against a gradient background, representing the company's transformation.
Feb 18, 2025

Philip Morris Smoke-Free Transformation: Zyn and IQOS Growth

Philip Morris drives a smoke‐free transformation with strong Q4 earnings and robust growth in Zyn and IQOS amid evolving regulatory challenges.

Read more →

Professional-grade financial analysis tools for informed investment decisions.

Product

  • Features
  • Pricing

Resources

  • Blog
  • Knowledge Base
  • Community
  • Market Data

Company

  • About
  • Careers
  • Contact
  • Partners

Legal

  • Privacy
  • Terms
  • License
  • Security

© 2025 Monexa. All rights reserved. Market data provided by financial exchanges and may be delayed as specified by financial exchanges or our data providers.